CHU de Bordeaux, Laboratoire d'Hématologie, Pessac, France.
INSERM UMR 1034, Biology of Cardiovascular Disease, University of Bordeaux, Pessac, France.
Clin Sci (Lond). 2020 May 29;134(10):1181-1190. doi: 10.1042/CS20200403.
Autosomal dominant inherited Protein S deficiency (PSD) (MIM 612336) is a rare disorder caused by rare mutations, mainly located in the coding sequence of the structural PROS1 gene, and associated with an increased risk of venous thromboembolism. To identify the molecular defect underlying PSD observed in an extended French pedigree with seven PSD affected members in whom no candidate deleterious PROS1 mutation was detected by Sanger sequencing of PROS1 exons and their flanking intronic regions or via an multiplex ligation-dependent probe amplification (MLPA) approach, a whole genome sequencing strategy was adopted. This led to the identification of a never reported C to T substitution at c.-39 from the natural ATG codon of the PROS1 gene that completely segregates with PSD in the whole family. This substitution ACG→ATG creates a new start codon upstream of the main ATG. We experimentally demonstrated in HeLa cells that the variant generates a novel overlapping upstream open reading frame (uORF) and inhibits the translation of the wild-type PS. This work describes the first example of 5'UTR PROS1 mutation causing PSD through the creation of an uORF, a mutation that is not predicted to be deleterious by standard annotation softwares, and emphasizes the need for better exploration of such type of non-coding variations in clinical genomics.
常染色体显性遗传蛋白 S 缺乏症(PSD)(MIM 612336)是一种罕见的疾病,由罕见的突变引起,主要位于结构 PROS1 基因的编码序列中,与静脉血栓栓塞风险增加有关。为了确定在一个扩展的法国家系中观察到的 PSD 的分子缺陷,该家系中有 7 名 PSD 受影响成员,通过 PROS1 外显子及其侧翼内含子区域的 Sanger 测序或通过多重连接依赖性探针扩增(MLPA)方法均未检测到候选有害 PROS1 突变,采用了全基因组测序策略。这导致鉴定了一个从未报道过的 C 到 T 取代,位于 PROS1 基因的自然 ATG 密码子的-39 位,该取代与整个家族中的 PSD 完全分离。该取代 ACG→ATG 在主要 ATG 上游创建了一个新的起始密码子。我们在 HeLa 细胞中进行的实验表明,该变体产生了一个新的重叠上游开放阅读框(uORF),并抑制了野生型 PS 的翻译。这项工作描述了第一个通过创建 uORF 导致 PSD 的 5'UTR PROS1 突变的例子,这种突变不是由标准注释软件预测的有害突变,并强调了在临床基因组学中需要更好地探索这种非编码变异类型。